<DOC>
	<DOCNO>NCT01101841</DOCNO>
	<brief_summary>To assess safety efficacy Brisdelle ( paroxetine mesylate ) Capsules 7.5 mg treatment vasomotor symptom ( VMS ) associate menopause</brief_summary>
	<brief_title>24-Week Efficacy &amp; Safety Study Brisdelle™ ( Formerly Known Mesafem ) Treatment Vasomotor Symptoms</brief_title>
	<detailed_description>The study 24-week , multicenter , double-blind , randomize , placebo-controlled study Brisdelle ( paroxetine mesylate ) Capsules 7.5 mg subject moderate severe postmenopausal VMS , define follow : 1 . Moderate VMS : Sensation heat sweating , able continue activity 2 . Severe VMS : Sensation heat sweating , cause cessation activity The study comprise screening period , run-in period , baseline visit , double-blind treatment period .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>1 . Female , &gt; 40 year age 2 . Reported 78 moderate severe hot flash per day ( average ) 5060 moderate severe hot flash per week least 30 day prior 3 . Spontaneous amenorrhea least 12 consecutive month 4 . Amenorrhea least 6 month meet biochemical criterion menopause 5 . Bilateral salpingooophorectomy &gt; 6 week without hysterectomy 1 . BMI ≥ 40 kg/m² 2 . Known nonresponder previous Selective serotonin reuptake inhibitor ( SSRI ) Serotonin norepinephrine reuptake inhibitor ( SNRI ) treatment VMS 3 . History selfinjurious behavior 4 . History clinical diagnosis depression ; treatment depression 5 . History clinical diagnosis borderline personality disorder 6 . Use investigational study medication within 30 day prior screen study 7 . Concurrent participation another clinical trial previous participation trial 8 . Family investigationalsite staff</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Vasomotor Symptoms</keyword>
	<keyword>Menopause</keyword>
	<keyword>Hot Flashes</keyword>
	<keyword>Perimenopause</keyword>
	<keyword>Nonhormonal therapy</keyword>
	<keyword>Climacteric symptom</keyword>
	<keyword>Mesafem</keyword>
	<keyword>Low-Dose Mesylate salt Paroxetine ( LDMP )</keyword>
</DOC>